Iromed Group

Iromed Group is a South Korean biotechnology and healthcare company that specializes in the integration of nutritional science and advanced medical therapies. Founded in 2001 by Dr. Seong-Joo Hwang, the company operates as the research and medical arm of the larger Irom Group. Its primary focus is the development of immune cell therapies, specifically Natural Killer (NK) and Cytokine-Induced Killer (CIK) cell treatments for various cancers. Additionally, Iromed conducts extensive research into natural product-derived therapeutics, such as the ER-7 compound for bone health and osteoporosis. The company also manages specialized clinics that provide holistic and integrative care for cancer patients, combining conventional medicine with immune-boosting protocols. Through its Total Health Care approach, Iromed Group aims to provide comprehensive solutions for disease prevention and regenerative medicine.